Researchers Describe Possible Mechanism for Distorted Cognition in SLE

October 24th 2021, 1:00am


The issue of systemic lupus erythematosus (SLE) is particularly important in Asia, because patients there suffer from more severe disease and damage compared with patients in Western countries.

New Guidelines Include Updates for CLE Treatment, Management

October 14th 2021, 5:00pm


An international group of researchers devised updated guidelines on the management and treatment of cutaneous lupus erythematosus (CLE).

Neuromuscular Ultrasonography May Have Potential in Assessing SLE

October 1st 2021, 11:00am


A new study suggests the lower-cost, more patient-friendly assessment method may be a useful tool for clinicians.

Belimumab Has Favorable Safety, Efficacy in Patients With SLE

September 27th 2021, 5:00pm


This new study adds to the literature by giving the first long-term data in these populations.

Study: Immunosuppressant Withdrawal Feasible, Safe for Many Patients With SLE and Lupus Nephritis

September 25th 2021, 2:00pm


A minority of patients will experience flares, but in most cases reintroduction of therapy will result in remission.

IV Belimumab for SLE Reduces Flare-Ups, Oral Corticosteroid Use

September 23rd 2021, 8:10pm


Intravenous belimumab had benefits, but also resulted in more health care utilization due to the nature of its administration.

Treat-to-Target Strategy Has Treatment Potential in Pediatric Lupus Nephritis

September 17th 2021, 12:00pm


Treat-to-target has long been used in adults, but a new study finds it is warranted in pediatric cases, too.

Belimumab Shows Promise in Small Cohort of Adults With NPSLE

September 15th 2021, 5:00pm


Five case reports suggested the anti-BAFF monoclonal antibody was effective at reducing disease activity scores for adults who have neuropsychiatric systemic lupus erythematosus (NPSLE).

Case Report Underscores Varied Nature of SLE Presentation

September 8th 2021, 8:15pm


A case report details the presentation of systemic lupus erythematous in a young, previously healthy individual.

Therapy Satisfaction High Among Patients With SLE, Although Burdens Remain

September 1st 2021, 5:10pm


Patients with systemic lupus erythematosus (SLE) said they still suffered significant pain and fatigue, even though they reported high rates of satisfaction with their therapies.